Skip to content

Glaukos GKOS Net Income

Net Income at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$5.24B-52.4%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$727.2M-10.1%
AbbVie logo
AbbVieABBV
$695M-46.0%
Boston Scientific logo
Boston ScientificBSX
$1.34B+99.3%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
-$77.9M-189%
Exelixis logo
ExelixisEXEL
$210.47M+31.9%

Segments

By segment

See full
Development And Commercialization Of Ophthalmic Therapies-$19.78M-9.0%

Other financials

Income statement

See full
Revenue$150.6M+41.2%
Gross profit$117.2M+42.4%
Operating income-$19.9M+4.0%
EPS (diluted)-$0.34-6.3%

Balance sheet

See full
Cash & equivalents$104.2M-8.8%
Total debt$105.9M-1.7%
Total equity$670.9M-12.2%
Total assets$893.3M-7.5%

Cash flow

See full
Operating cash flow-$12.5M+32.4%
CapEx$4.0M+104%
Free cash flow-$16.5M+19.4%

Valuation

See full
Market cap$7.68B+12.3%
Enterprise value$7.68B+12.5%
P/S13.9×-3.0×

Profitability

See full
Gross margin78.1%+2.3pp
Operating margin-36.1%+24.3pp
Net margin-34.3%+4.8pp
FCF margin-13.2%-3.9pp

Returns & leverage

See full
Return on equity-26.4%+11.1pp
Debt / equity0.2×0.0×
Current ratio5.4×-1.1×

Where this comes from

Reported directly by Glaukos in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Glaukos’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Glaukos's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Glaukos's net income?
Glaukos (GKOS) reported net income of -$19.78M in Q1 2026.
How has Glaukos's net income changed year-over-year?
Glaukos's net income decreased by 9.0% year-over-year, from -$18.15M to -$19.78M.
What is the long-term trend for Glaukos's net income?
Over 4 years (2021 to 2025), Glaukos's net income has grown at a 39.5% compound annual growth rate (CAGR), from -$49.59M to -$187.69M.
What does net income mean?
The total profit or loss of the company after all costs and taxes.
How do you interpret net income?
A positive and growing net income is the primary indicator of long-term financial health and shareholder value creation.
How does net income compare across companies?
The most common benchmark for evaluating overall corporate performance against industry peers.